SCHEMBL17883333

SCHEMBL17883333

O=C(NCCI)c1cc(-c2ccccc2)[nH]n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.48
NPC1 O15118 3/20 0.48
ALPL P05186 1/20 0.45
ALPI P09923 1/20 0.45
MAPT P10636 3/20 0.44
ALDH1A1 P00352 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HDAC3 O15379 2/20 0.41
HDAC4 P56524 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC7 Q8WUI4 2/20 0.41
HDAC2 Q92769 2/20 0.41
HDAC10 Q969S8 2/20 0.41
HDAC11 Q96DB2 2/20 0.41
HDAC8 Q9BY41 2/20 0.41
HDAC6 Q9UBN7 2/20 0.41
HDAC9 Q9UKV0 2/20 0.41
HDAC5 Q9UQL6 2/20 0.41
POLB P06746 1/20 0.41
PRKD1 Q15139 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17511039 0.87 RAB9A (0.49) RAB9ANPC1ALPLALPIMAPT
SCHEMBL17511067 0.86 RAB9A (0.48) RAB9ANPC1ALPLALPIMAPT
SCHEMBL17511304 0.85 HDAC3 (0.47) RAB9ANPC1ALPLALPIMAPT
SCHEMBL19440809 0.84 NPC1 (0.56) RAB9ANPC1MAPTALDH1A1SMN1; SMN2
SCHEMBL17883357 0.84 ITK (0.53) RAB9ANPC1ALDH1A1SMN1; SMN2PRKD1
SCHEMBL69243 0.83 RAB9A (0.50) RAB9ANPC1ALPLALPIMAPT
SCHEMBL17511046 0.82 RAB9A (0.52) RAB9ANPC1MAPTALDH1A1
SCHEMBL19440896 0.82 RAB9A (0.44) RAB9ANPC1ALPLALPIMAPT
SCHEMBL27833483 0.81 MEN1 (0.46) RAB9ANPC1ALPLALPIMAPT
SCHEMBL19440886 0.80 NAMPT (0.47) RAB9ANPC1ALDH1A1SMN1; SMN2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016105484-A1 DERIVATIVES OF 5-(HETERO)ARYLPYRAZOL-3-CARBOXYLIC AMIDE OR 1-(HETERO)ARYLTRIAZOL-4-CARBOXYLIC AMIDE USEFUL FOR THE TREATMENT OF INTER ALIA CYSTIC FIBROSIS PROTEOSTASIS THERAPEUTICS, INC. (US) 2016-06-30 WO disclosed